healthcare policy
Research Paper
A North Star Vision: Results from a Deliberative Dialogue to Identify Policy Strategies to Improve Value in Healthcare
Amity E. Quinn, Rachelle Drummond, Fiona Clement, Melanie Columbus, Stephana J. Moss, Emily FitzGera...
Support For Underserved Communities
Recommendations to Enhance Physical Health for Individuals with Severe Mental Illness in Canadian Healthcare Organizations
Tania Tajirian, Cristina de Lasa, Caroline Chessex, Brian Lo, Po-Yen (Brian) Chang, Rola Moghabghab,...
Discussion and Debate
Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion
Sarah Kratina, Christopher Lo, Carol Strike, Robert Schwartz and Brian Rush
Discussion and Debate
Commentary: Access to Psychedelics for Psychological Suffering at the End of Life – Prioritizing Our Priorities
Daniel Rosenbaum, Sarah Hales and Daniel Z. Buchman
Editorial
Provinces and Territories Are Overdue for an Update in Healthcare Funding Policies
Jason M. Sutherland
Discussion and Debate
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
Shoo K. Lee, Sukhy K. Mahl, Jessica J. Green and Joel Lexchin
Discussion and Debate
Commentary: Reconsidering Pharmaceutical Research and Development Investments
Marc-André Gagnon
Research Paper
Nursing Home Residents’ Use of Radiography in New Brunswick: A Case for Mobile Radiography?
Eric Plant, Rose McCloskey, Isdore Chola Shamputa, Kavish Chandra, Paul Atkinson, Jacqueline Fraser,...
Invited Paper
Expensive Drugs for Rare Diseases in Canada: What Value and At What Cost?
Sandra Sirrs, Helen Anderson, Bashir Jiwani, Larry D. Lynd, Eric Lun, Bob Nakagawa, Dean Regier, Shi...
Commentary
Expensive Drug Prices for Rare Cancers: Are Patients Truly Benefitting?
Kristina Jenei and Bishal Gyawali